|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Cancer Institute (NCI) |
|---|---|
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00556582 |
Purpose
RATIONALE: Gathering information about patients with a personal or family history of cancer associated with a virus may help doctors learn more about the disease.
PURPOSE: This clinical trial is studying patients with a personal or family history of cancer caused by a virus.
| Condition | Intervention |
|---|---|
|
Lymphoma Lymphoproliferative Disorder Sarcoma Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific |
Other: biologic sample preservation procedure Other: cytology specimen collection procedure Other: immunologic technique Procedure: biopsy Procedure: study of high risk factors |
| Study Type: | Observational |
| Official Title: | Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers |
| Estimated Enrollment: | 200 |
| Study Start Date: | December 1996 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Patients undergo an interview, physical examination, and blood sample collection. Other clinically indicated biological samples, such as urine, sputum, saliva, tears, or semen or cervical, anal, oral, or nasal swabs, are collected. Skin testing with conventional, licensed antigens for assessment of cellular immunity may be performed, and skin lesions may be biopsied or excised. Tumor or other tissue biopsies may be obtained when biopsy or surgery is clinically indicated. The biological samples are frozen or preserved for current or future research studies.
Patients receive counseling relevant to the disease under study, and about the interim study results. Clinical referrals are made as needed.
Eligibility| Ages Eligible for Study: | up to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Personal or family history of viral-associated neoplasia of an unusual type, pattern, or number including, but not limited to, the following:
Known or suspected factor(s) predisposing to neoplasia, including any of the following:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
Contacts and Locations| United States, Maryland | |
| Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | Recruiting |
| Bethesda, Maryland, United States, 20892-1182 | |
| Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937 | |
| Principal Investigator: | James J. Goedert, MD | National Cancer Institute (NCI) |
More Information
| Study ID Numbers: | CDR0000566031, NCI-97-C-0028 |
| Study First Received: | November 9, 2007 |
| Last Updated: | February 6, 2009 |
| ClinicalTrials.gov Identifier: | NCT00556582 History of Changes |
| Health Authority: | Unspecified |
|
Kaposi sarcoma AIDS-related lymphoma adult Hodgkin lymphoma childhood Hodgkin lymphoma angioimmunoblastic T-cell lymphoma adult Burkitt lymphoma adult diffuse large cell lymphoma adult diffuse mixed cell lymphoma adult diffuse small cleaved cell lymphoma adult immunoblastic large cell lymphoma small intestine lymphoma intraocular lymphoma primary central nervous system lymphoma |
post-transplant lymphoproliferative disorder adult grade III lymphomatoid granulomatosis childhood grade III lymphomatoid granulomatosis childhood immunoblastic large cell lymphoma childhood diffuse large cell lymphoma childhood small noncleaved cell lymphoma Burkitt lymphoma adult T-cell leukemia/lymphoma unspecified adult solid tumor, protocol specific unspecified childhood solid tumor, protocol specific adult nasal type extranodal NK/T-cell lymphoma childhood nasal type extranodal NK/T-cell lymphoma |
|
Hodgkin Lymphoma, Childhood Gastrointestinal Diseases Central Nervous System Lymphoma, Primary Ileal Diseases Lymphoma, Large-cell, Immunoblastic Kaposi Sarcoma Lymphoma, Small Cleaved-cell, Diffuse Duodenal Neoplasms Neoplasms, Connective and Soft Tissue Leukemia Soft Tissue Sarcomas Lymphoma, AIDS-Related Ileal Neoplasms Lymphoma, T-Cell Lymphoma, Large-Cell, Immunoblastic |
Lymphoma, Large-cell Hodgkin Disease Lymphoma Duodenal Diseases Lymphoma, AIDS-related Jejunal Neoplasms Lymphoma, Large B-Cell, Diffuse Lymphomatoid Granulomatosis Immunoproliferative Disorders Digestive System Neoplasms Hodgkin Lymphoma, Adult Leukemia-Lymphoma, Adult T-Cell Sarcoma, Kaposi Immunoblastic Lymphadenopathy Hodgkin's Disease |
|
Jejunal Neoplasms Digestive System Neoplasms Neoplasms by Histologic Type Immunoproliferative Disorders Immune System Diseases Gastrointestinal Diseases Intestinal Diseases Ileal Diseases Intestinal Neoplasms Duodenal Neoplasms Neoplasms, Connective and Soft Tissue |
Lymphatic Diseases Neoplasms Digestive System Diseases Neoplasms by Site Ileal Neoplasms Jejunal Diseases Sarcoma Gastrointestinal Neoplasms Lymphoproliferative Disorders Lymphoma Duodenal Diseases |
